Latest Articles

Publication Date
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study - Cureus

Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study Cureus

Published: Feb. 27, 2026, 7:22 a.m.
Probe into Sanitary Pad Brands Over Chemical Safety Concerns - Jacaranda FM

Probe into Sanitary Pad Brands Over Chemical Safety Concerns Jacaranda FM

Published: Feb. 25, 2026, 7:09 a.m.
Front Porch Youth Assessment Center hosts 4th annual Summer Camp Buffet - WTOC

Front Porch Youth Assessment Center hosts 4th annual Summer Camp Buffet WTOC

Published: Feb. 19, 2026, 3:45 p.m.
UGA Forest Education Center to host annual fire safety festival in Guyton - WTOC

UGA Forest Education Center to host annual fire safety festival in Guyton WTOC

Published: Feb. 18, 2026, 4:34 p.m.
A Lifetime of Pain: How Generations of Women Learn to Endure Pelvic Agony - streamlinefeed.co.ke

A Lifetime of Pain: How Generations of Women Learn to Endure Pelvic Agony streamlinefeed.co.ke

Published: Feb. 17, 2026, 5:33 a.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology

Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com

Published: Jan. 22, 2026, 4:02 p.m.
Terumo launches SurTract Safety Syringe in U.S. - Med-Tech Insights

Terumo launches SurTract Safety Syringe in U.S. Med-Tech Insights

Published: Jan. 6, 2026, 4:18 p.m.
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology

Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology

Published: Dec. 22, 2025, 1:15 p.m.
Dow Update: What dividend safety score for REPX stock - 2025 Risk Factors & Free Expert Verified Stock Movement Alerts - moha.gov.vn

Dow Update: What dividend safety score for REPX stock - 2025 Risk Factors & Free Expert Verified Stock Movement Alerts moha.gov.vn

Published: Dec. 21, 2025, 8:03 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!